BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37460202)

  • 21. Diagnostic criteria for constitutional mismatch repair deficiency (CMMRD): recommendations from the international consensus working group.
    Aronson M; Colas C; Shuen A; Hampel H; Foulkes WD; Baris Feldman H; Goldberg Y; Muleris M; Wolfe Schneider K; McGee RB; Jasperson K; Rangaswami A; Brugieres L; Tabori U
    J Med Genet; 2022 Apr; 59(4):318-327. PubMed ID: 33622763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric High Grade Gliomas in the Context of Cancer Predisposition Syndromes.
    Michaeli O; Tabori U
    J Korean Neurosurg Soc; 2018 May; 61(3):319-332. PubMed ID: 29742882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroimaging Findings in Children with Constitutional Mismatch Repair Deficiency Syndrome.
    Kerpel A; Yalon M; Soudack M; Chiang J; Gajjar A; Nichols KE; Patay Z; Shrot S; Hoffmann C
    AJNR Am J Neuroradiol; 2020 May; 41(5):904-910. PubMed ID: 32354708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of Cancer Predisposition Syndromes in a National Cohort of Children With a Neoplasm.
    Bakhuizen JJ; Hopman SMJ; Bosscha MI; Dommering CJ; van den Heuvel-Eibrink MM; Hol JA; Kester LA; Koudijs MJ; Langenberg KPS; Loeffen JLC; van der Lugt J; Moll AC; van Noesel MM; Smetsers SE; de Vos-Kerkhof E; Merks JHM; Kuiper RP; Jongmans MCJ
    JAMA Netw Open; 2023 Feb; 6(2):e2254157. PubMed ID: 36735256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort.
    Lavoine N; Colas C; Muleris M; Bodo S; Duval A; Entz-Werle N; Coulet F; Cabaret O; Andreiuolo F; Charpy C; Sebille G; Wang Q; Lejeune S; Buisine MP; Leroux D; Couillault G; Leverger G; Fricker JP; Guimbaud R; Mathieu-Dramard M; Jedraszak G; Cohen-Hagenauer O; Guerrini-Rousseau L; Bourdeaut F; Grill J; Caron O; Baert-Dusermont S; Tinat J; Bougeard G; Frébourg T; Brugières L
    J Med Genet; 2015 Nov; 52(11):770-8. PubMed ID: 26318770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Genetic predisposition to childhood cancer].
    Ripperger T; Schlegelberger B
    Pathologe; 2018 Dec; 39(Suppl 2):306-310. PubMed ID: 30397787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer predisposition syndromes as a risk factor for early second primary neoplasms after childhood cancer - A national cohort study.
    Waespe N; Belle FN; Redmond S; Schindera C; Spycher BD; Rössler J; Ansari M; Kuehni CE;
    Eur J Cancer; 2021 Mar; 145():71-80. PubMed ID: 33423008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The great mimicker: Phenotypic overlap between constitutional mismatch repair deficiency and Tuberous Sclerosis complex.
    Shapira Rootman M; Goldberg Y; Cohen R; Kropach N; Keidar I; Friedland R; Dotan G; Konen O; Toledano H
    Clin Genet; 2020 Feb; 97(2):296-304. PubMed ID: 31730237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Management and Tumor Surveillance Recommendations of Inherited Mismatch Repair Deficiency in Childhood.
    Tabori U; Hansford JR; Achatz MI; Kratz CP; Plon SE; Frebourg T; Brugières L
    Clin Cancer Res; 2017 Jun; 23(11):e32-e37. PubMed ID: 28572265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recognizing and Managing Children with a Pediatric Cancer Predisposition Syndrome: A Guide for the Pediatrician.
    Coury SA; Schneider KA; Schienda J; Tan WH
    Pediatr Ann; 2018 May; 47(5):e204-e216. PubMed ID: 29750288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heritable cancer predisposition testing in pediatric cancer patients excluding retinoblastoma in a middle-income country.
    El Khatib O; Yahya Y; Mahfouz R; Hamadeh L; Basbous M; Abboud MR; Muwakkit S; Rodriguez-Galindo C; Jeha S; Saab R
    Pediatr Blood Cancer; 2022 Nov; 69(11):e29982. PubMed ID: 36094320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on cancer predisposition syndromes and surveillance guidelines for childhood brain tumors.
    Hansford JR; Das A; McGee RB; Nakano Y; Brzezinski J; Scollon SR; Rednam SP; Schienda J; Michaeli O; Kim SY; Greer MC; Weksberg R; Stewart DR; Foulkes WD; Tabori U; Pajtler KW; Pfister SM; Brodeur GM; Kamihara J
    Clin Cancer Res; 2024 Apr; ():. PubMed ID: 38573059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic testing and prevention of hereditary cancer at the MMCI--over 10 years of experience.
    Foretova L; Petrakova K; Palacova M; Kalabova R; Svoboda M; Navratilova M; Schneiderova M; Bolcak K; Krejci E; Drazan L; Mikova M; Hazova J; Vasickova P; Machackova E
    Klin Onkol; 2010; 23(6):388-400. PubMed ID: 21348412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetics of Common Pediatric Brain Tumors.
    Malbari F; Lindsay H
    Pediatr Neurol; 2020 Mar; 104():3-12. PubMed ID: 31948735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric cancer and Li-Fraumeni/Li-Fraumeni-like syndromes: a review for the pediatrician.
    Giacomazzi CR; Giacomazzi J; Netto CB; Santos-Silva P; Selistre SG; Maia AL; Oliveira VZ; Camey SA; Goldim JR; Ashton-Prolla P
    Rev Assoc Med Bras (1992); 2015; 61(3):282-9. PubMed ID: 26248253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The need for tumor surveillance of children and adolescents with cancer predisposition syndromes: a retrospective cohort study in a tertiary-care children's hospital.
    Huber S; Schimmel M; Dunstheimer D; Nemes K; Richter M; Streble J; Vollert K; Walden U; Frühwald MC; Kuhlen M
    Eur J Pediatr; 2022 Apr; 181(4):1585-1596. PubMed ID: 34950979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION, Number 793.
    Obstet Gynecol; 2019 Dec; 134(6):e143-e149. PubMed ID: 31764758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION SUMMARY, Number 793.
    Obstet Gynecol; 2019 Dec; 134(6):1366-1367. PubMed ID: 31764755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic Performance of Whole-Body MRI as a Tool for Cancer Screening in Children With Genetic Cancer-Predisposing Conditions.
    Anupindi SA; Bedoya MA; Lindell RB; Rambhatla SJ; Zelley K; Nichols KE; Chauvin NA
    AJR Am J Roentgenol; 2015 Aug; 205(2):400-8. PubMed ID: 26204294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.